{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T15:55:10Z","timestamp":1793548510766,"version":"4.5.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004224","name":"Peter MacCallum Cancer Centre","doi-asserted-by":"publisher","award":["VGH\/BWT"],"award-info":[{"award-number":["VGH\/BWT"]}],"id":[{"id":"10.13039\/501100004224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In patients early post\u2013autologous stem cell transplant, seroprotection rates were high for Hemophilus influenzae type B and tetanus toxoid (70%\u201390%) but lower for Streptococcus pneumoniae (30%\u201350%) including after revaccination. There were high rates of seropositivity (67%\u201386%) to measles, mumps, and rubella and varicella zoster virus. Durability of protection requires assessment.<\/jats:p>","DOI":"10.1093\/ofid\/ofad497","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T01:41:29Z","timestamp":1696556489000},"source":"Crossref","is-referenced-by-count":3,"title":["High Rates of Seroprotection and Seroconversion to Vaccine-Preventable Infections in the Early Post\u2013Autologous Stem Cell Transplant Period"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9353-0059","authenticated-orcid":false,"given":"Victoria G","family":"Hall","sequence":"first","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne , Parkville , Australia"},{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie R","family":"Saunders","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Klimevski","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayani S","family":"Tennakoon","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Khot","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne , Parkville , Australia"},{"name":"Department of Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital , Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Harrison","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne , Parkville , Australia"},{"name":"Department of Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital , Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon J","family":"Worth","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne , Parkville , Australia"},{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle K","family":"Yong","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne , Parkville , Australia"},{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne , Australia"},{"name":"Department of Infectious Diseases, Royal Melbourne Hospital , Parkville , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A","family":"Slavin","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne , Parkville , Australia"},{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne , Australia"},{"name":"Department of Infectious Diseases, Royal Melbourne Hospital , Parkville , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0213-5470","authenticated-orcid":false,"given":"Benjamin W","family":"Teh","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne , Parkville , Australia"},{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"2023102013184103200_ofad497-B1","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2023102013184103200_ofad497-B2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023102013184103200_ofad497-B3","doi-asserted-by":"crossref","first-page":"245.e1","DOI":"10.1016\/j.jtct.2020.11.009","article-title":"Serological response to vaccination after autologous transplantation for multiple myeloma is associated with improved progression-free and overall survival","volume":"27","author":"Merz","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"2023102013184103200_ofad497-B4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbmt.2017.12.795","article-title":"Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance","volume":"24","author":"Palazzo","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023102013184103200_ofad497-B5","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41409-018-0112-x","article-title":"Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation","volume":"53","author":"Pandit","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"2023102013184103200_ofad497-B6","doi-asserted-by":"crossref","first-page":"e4269","DOI":"10.1093\/cid\/ciaa1711","article-title":"A randomised trial of two 2-dose influenza vaccination strategies for patients following autologous haematopoietic stem cell transplantation","volume":"73","author":"Teh","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023102013184103200_ofad497-B7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00430-013-0292-3","article-title":"Reference ranges and cutoff levels of pneumococcal antibody global serum assays (IgG and IgG2) and specific antibodies in healthy children and adults","volume":"202","author":"Rose","year":"2013","journal-title":"Med Microbiol Immunol"},{"issue":"Suppl 3","key":"2023102013184103200_ofad497-B8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"2023102013184103200_ofad497-B9","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM198406143102404","article-title":"Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine","volume":"310","author":"Peltola","year":"1984","journal-title":"N Engl J Med"},{"key":"2023102013184103200_ofad497-B10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM199503233321201","article-title":"A population-based serologic survey of immunity to tetanus in the United States","volume":"332","author":"Gergen","year":"1995","journal-title":"N Engl J Med"},{"key":"2023102013184103200_ofad497-B11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jtct.2021.01.017","article-title":"An immune recovery-based revaccination protocol for pediatric hematopoietic stem cell transplant recipients: revaccination outcomes following pediatric HSCT","volume":"27","author":"Haynes","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"2023102013184103200_ofad497-B12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V84.2.657.657","article-title":"Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation","volume":"84","author":"Ljungman","year":"1994","journal-title":"Blood"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad497\/51906617\/ofad497.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/10\/ofad497\/52304781\/ofad497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/10\/ofad497\/52304781\/ofad497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T17:58:11Z","timestamp":1697824691000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad497\/7292956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,30]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad497","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10]]},"published":{"date-parts":[[2023,9,30]]},"article-number":"ofad497"}}